The value of SREBF2-AS1 in HCC remains to be confirmed, but a study has found it can be used as ferroptosis-related lncRNA to predict the prognosis and immune activity of HCC (Chen Z. A. et al., 2021). This evidence concerns the gene SREBF2 and hepatocellular carcinoma.